Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
2.530
-0.130 (-4.89%)
At close: Feb 21, 2025, 4:00 PM
2.580
+0.050 (1.98%)
After-hours: Feb 21, 2025, 7:50 PM EST
Evaxion Biotech Market Cap
Evaxion Biotech has a market cap or net worth of $15.85 million as of February 21, 2025. Its market cap has decreased by -54.85% in one year.
Market Cap
15.85M
Enterprise Value
11.28M
1-Year Change
-54.85%
Ranking
Category
Stock Price
$2.53
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion Biotech's market cap has decreased from $191.99M to $15.85M, a decrease of -91.74%. That is a compound annual growth rate of -46.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 15.85M | 219.70% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |